Rheumatology news & research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Rheumatology

MRI study suggest NSAIDs may worsen arthritis inflammation

MRI study suggest NSAIDs may worsen arthritis inflammation

MRI derived radiomics based nomogram predicts improvement in osteoarthritis knee pain

MRI derived radiomics based nomogram predicts improvement in osteoarthritis knee pain

Low-dose aspirin use linked to increased risk of serious falls in elderly

Low-dose aspirin use linked to increased risk of serious falls in elderly

Hyaluronic acid ineffective for pain management in knee osteoarthritis

Hyaluronic acid ineffective for pain management in knee osteoarthritis

Stopping methotrexate for 2 weeks after COVID-19 vaccination boosts immune response

Stopping methotrexate for 2 weeks after COVID-19 vaccination boosts immune response

Walking for exercise significantly reduces in new frequent knee pain in osteoarthritis

Walking for exercise significantly reduces in new frequent knee pain in osteoarthritis

Psoriasis patients self-report higher analgesic usage largely due to joint pain

Psoriasis patients self-report higher analgesic usage largely due to joint pain

Vitamin D and omega-3 fatty acids reduce autoimmune disease incidence

Vitamin D and omega-3 fatty acids reduce autoimmune disease incidence

Oral upadacitinib approved by NICE for active psoriatic arthritis

Oral upadacitinib approved by NICE for active psoriatic arthritis

Podcast: Self-management strategies in inflammatory arthritis

Podcast: Self-management strategies in inflammatory arthritis

Risankizumab receives MHRA approval for psoriatic arthritis

Risankizumab receives MHRA approval for psoriatic arthritis

Risankizumab approved by EMA for active psoriatic arthritis

Risankizumab approved by EMA for active psoriatic arthritis

Healthy lifestyle associated with lower risk of systemic lupus erythematosus

Healthy lifestyle associated with lower risk of systemic lupus erythematosus

Anifrolumab approved by FDA for systemic lupus erythematosus

Anifrolumab approved by FDA for systemic lupus erythematosus

Inception cohort study revealed that a third of RA patients experienced long-term pain

Inception cohort study revealed that a third of RA patients experienced long-term pain

Early biologic use in systemic juvenile idiopathic arthritis reduces need for steroids

Early biologic use in systemic juvenile idiopathic arthritis reduces need for steroids

Gradual withdrawal of steroids safe in systemic lupus erythematosus

Gradual withdrawal of steroids safe in systemic lupus erythematosus

Upadacitinib effective over one year in ankylosing spondylitis

Upadacitinib effective over one year in ankylosing spondylitis

x